Abrashkina E D, Shaalali N, Pakhrova O A, Shutemova E A, Nazarova O A
Kardiologiia. 2010;50(5):25-8.
We assessed effect of 6-weeks therapy with atorvastatin on parameters of lipid metabolism and some hemorheological characteristics in 27 patients with arterial hypertension (AH) and dyslipoproteinemia (DLP). In addition to general clinical examination we studied hemorheological profile including hematocrit, blood plasma and whole blood viscosity with the method of rotational viscosimetry at various shear rates, deformability of erythrocytes by filtration method, and cytoarchitectonics of erythrocytes. At the background of pronounced lipid lowering effect of atorvastatin we noted obvious improvement of microrheological properties of erythrocytes appearing as significant decrease of rigidity index of erythrocytes and of their aggregation. Basing on these findings we concluded that improvement of fluidity of erythrocytes promoting facilitation of blood flow efficacy in microcirculatory vascular bed can be a supplementary reason for administration of atorvastatin to patients with AH and DLP.
我们评估了阿托伐他汀6周治疗对27例动脉高血压(AH)合并血脂蛋白异常(DLP)患者脂质代谢参数和一些血液流变学特征的影响。除常规临床检查外,我们还采用旋转粘度测定法研究了血液流变学指标,包括血细胞比容、血浆和全血在不同剪切速率下的粘度、通过过滤法测定的红细胞变形性以及红细胞的细胞结构。在阿托伐他汀显著降低血脂的背景下,我们注意到红细胞的微观流变学特性有明显改善,表现为红细胞刚性指数及其聚集性显著降低。基于这些发现,我们得出结论,红细胞流动性的改善促进了微循环血管床中血流效率,这可能是阿托伐他汀用于AH和DLP患者的一个补充理由。